Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemoradiation Combined With Panitumumab Followed by Surgery for Patients With Operable Esophageal Cancer

NCT01077999 is registered in ClinicalTrials.gov with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor.

NCT NCT01077999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01077999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemoradiation Combined With Panitumumab Followed by Surgery for Patients With Operable Esophageal Cancer
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2010
Completion date
April 30, 2012
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, esophageal cancer, gastro-esophageal junction cancer, squamous cell carcinoma